Each year, more than 500 University of Bristol students are awarded doctorates for their ground-breaking and fascinating research. And each year, a panel of senior University academics have the difficult task of picking six of the best theses to receive Doctoral Prizes.
A total of more than £5 million of funding has been awarded to three University of Bristol projects through the European Research Council (ERC) Consolidator Grants announced today (Tuesday 3 December 2024).
Factors beyond carbohydrates have a substantial influence on blood glucose levels meaning current automated insulin delivery systems miss vital information required for glucose regulation, a new study has found.
There is a major need to understand the changing global health landscape due to the social and economic effects of globalisation. Many factors, including increases in migration, urbanisation, climate change and world-wide instability, call for an interdisciplinary approach to research and a need to develop international partnerships to tackle the many issues of human health that can only be addressed in a global context.
A new study has found that community pharmacies could play a significant role in expanding access to pre-exposure prophylaxis (PrEP), a highly effective pill for preventing HIV infection. The researchers found that pharmacies could provide a more convenient and discreet option for those who are underserved by the current model of PrEP delivery through sexual health clinics in England.
Two new studies to understand more about type 1 diabetes and how it develops in people who already have early markers of the disease in their blood are announced today [14 November] on World Diabetes Day. The awards, totalling over £1 million will help University of Bristol researchers find out how the disease, which affects up to 400,000 people in the UK, could be prevented in future.
A £5.5 million award for research that will help protect the public from health threats has been secured by the University of Bristol’s Health Protection Research Unit in Evaluation and Behavioural Science (HPRU-EBS).
A University of Bristol spinout company focused on transforming the way kidney diseases are treated has announced an £80m fund raising to help realise the development of a pivotal new therapeutic treatment.
A trial that showed a cheap and widely available prescription drug can improve symptoms of irritable bowel syndrome (IBS) in patients seen in GP surgeries has been awarded Research Paper of the Year by the Royal College of General Practitioners (RCGP).
These national awards celebrate the very best and brightest in the field of patient experience. Common Ambition has been shortlisted in two categories: ‘Commissioning for Patient Experience’ and ‘Partnership Working to Improve the Experience’.
